Inga, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 10.112
AS - Asia 2.238
EU - Europa 2.027
SA - Sud America 510
AF - Africa 46
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.952
Nazione #
US - Stati Uniti d'America 10.040
SG - Singapore 1.248
CN - Cina 484
RU - Federazione Russa 438
BR - Brasile 436
IT - Italia 303
SE - Svezia 230
VN - Vietnam 190
UA - Ucraina 188
FI - Finlandia 181
GB - Regno Unito 180
DE - Germania 177
LV - Lettonia 115
BG - Bulgaria 46
CA - Canada 45
ID - Indonesia 45
JO - Giordania 37
IN - India 36
HK - Hong Kong 34
TR - Turchia 32
JP - Giappone 31
AR - Argentina 28
FR - Francia 25
AT - Austria 23
NL - Olanda 23
MX - Messico 20
ES - Italia 19
BD - Bangladesh 18
ZA - Sudafrica 18
PL - Polonia 17
IQ - Iraq 16
CZ - Repubblica Ceca 15
GR - Grecia 12
EC - Ecuador 11
CO - Colombia 10
UZ - Uzbekistan 10
MA - Marocco 9
PK - Pakistan 9
AU - Australia 8
CL - Cile 8
LT - Lituania 8
DZ - Algeria 7
BE - Belgio 6
IE - Irlanda 6
KR - Corea 6
VE - Venezuela 6
A2 - ???statistics.table.value.countryCode.A2??? 4
IL - Israele 4
KE - Kenya 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
PE - Perù 4
PH - Filippine 4
SA - Arabia Saudita 4
AL - Albania 3
AZ - Azerbaigian 3
CH - Svizzera 3
KZ - Kazakistan 3
OM - Oman 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BO - Bolivia 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
LI - Liechtenstein 2
LU - Lussemburgo 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
QA - Qatar 2
SR - Suriname 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
GD - Grenada 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
NG - Nigeria 1
PS - Palestinian Territory 1
RO - Romania 1
TH - Thailandia 1
TM - Turkmenistan 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.952
Città #
Fairfield 1.386
Ashburn 1.132
Chandler 916
Singapore 802
Woodbridge 607
Seattle 599
Houston 509
Wilmington 456
Cambridge 453
Jacksonville 453
Dallas 403
Ann Arbor 276
Santa Clara 248
Columbus 230
Moscow 179
Princeton 171
San Mateo 159
New York 138
Riga 115
Beijing 109
Los Angeles 102
Trento 86
Helsinki 84
San Diego 77
Munich 68
Boardman 65
Council Bluffs 60
Dong Ket 55
São Paulo 55
Chicago 50
Dearborn 50
London 48
San Paolo di Civitate 45
Sofia 44
Jakarta 41
Lawrence 39
The Dalles 39
Fremont 38
Buffalo 36
Phoenix 36
Falls Church 35
Ho Chi Minh City 32
Hong Kong 32
Nuremberg 27
San Jose 27
Washington 27
Como 26
Tokyo 26
Hanoi 23
Hefei 22
North Bergen 22
Denver 20
Montreal 19
Redondo Beach 18
Bremen 17
Des Moines 17
Belo Horizonte 16
Izmir 15
Orem 15
Turku 15
Falkenstein 14
Norwalk 14
Rio de Janeiro 14
Warsaw 14
Atlanta 13
Johannesburg 13
Mountain View 13
Riva Del Garda 13
Brno 12
Brooklyn 12
Genoa 12
Poplar 12
Rome 12
Stockholm 12
Chennai 11
Frankfurt am Main 11
Vienna 11
Corinth 10
Elk Grove Village 10
Salt Lake City 10
Toronto 10
Brasília 8
Fuzhou 8
Kilburn 8
Lappeenranta 8
Shanghai 8
Shijiazhuang 8
Tashkent 8
Ankara 7
Guarulhos 7
Milan 7
Andover 6
Changsha 6
Chiswick 6
Deiva Marina 6
Guangzhou 6
Mexico City 6
Porto Alegre 6
Pune 6
Ribeirão Preto 6
Totale 11.294
Nome #
Inherited determinants of early recurrent somatic mutations in prostate cancer 308
Human transcription factors in yeast: the fruitful examples of P53 and NF-кB 294
Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway 282
A highly specific SpCas9 variant is identified by in vivo screening in yeast 261
The ribonucleic complex HuR-MALAT1 represses CD133 expression and suppresses epithelial-mesenchymal transition in breast cancer 244
Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development 223
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma 220
Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas 218
RiboAbacus: a model trained on polyribosome images predicts ribosome density and translational efficiency from mammalian transcriptomes 210
Whole-genome cartography of p53 response elements ranked on transactivation potential 206
c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma. 197
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells 193
A Cross-Platform Comparison of Affymetrix and Agilent Microarrays Reveals Discordant miRNA Expression in Lung Tumors of c-Raf Transgenic Mice 191
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity 191
Functional analysis of CDKN2A/p16INK4a 5 ' UTR variants predisposing to melanoma 187
Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay 186
A functional genetic study identifies HAND1 mutations in septation defects of the human heart. 184
DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties 178
Synthesis of 2,6-diamino-substituted purine derivatives and evaluation of cell cycle arrest in breast and colorectal cancer cells 177
Yeast as a chassis for developing functional assays to study human P53 176
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 168
Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach. 163
The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis. 163
P53 Family Members Modulate the Expression of PRODH, but Not PRODH2, via Intronic p53 Response Elements. 163
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 162
Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional Assay 160
Apigenin rich-Limonium duriusculum (de Girard) Kuntze promotes apoptosis in HCT116 cancer cells 160
Contribution of yeast and plant research for improving human health. 159
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β 158
p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system 154
Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson. 154
Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines 154
Translation control can shape TP53-dependent cell fate 154
JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress. 153
Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. 153
A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. 152
3-Methyl-3-deazaadenine, a stable isostere of N3-methyl-adenine, is efficiently bypassed by replication in vivo and by transcription in vitro. 151
EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences. 150
p53-directed translational control can shape and expand the universe of p53 target genes. 149
A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1. 148
Mutagenicity of N3-methyladenine: a multi-translesion polymerase affair. 146
In-silico identification and functional validation of allele-dependent AR enhancers 146
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 143
Structure of p73 DNA-binding domain tetramer modulates p73 transactivation. 143
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 143
TP53 Mutants in the Tower of Babel of Cancer Progression. 142
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics. 141
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes. 140
A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network 139
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation. 139
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma 138
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule 138
Functional analysis of CDKN2A 5'UTR variants associated with family history of melanoma 136
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer 136
Comparison of the biological effects of MMS and Me-lex, a minor groove methylating agent: Clarifying the role of N3-methyladenine. 135
A selective p53 activator and anticancer agent to improve colorectal cancer therapy 135
Cooperative interactions between p53 and NFκB enhance cell plasticity. 133
Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30 133
Α-mangostin and gambogic acid as potential inhibitors of the p53-MDM2 interaction revealed by a yeast approach. 131
The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound. 129
Characterization of the p53 mutants ability to inhibit p73β transactivation using a yeast-based functional assay 128
P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development 128
Identification of new p53 target microRNAs by bioinformatics and functional analysis 124
SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy 124
Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach. 122
The expanding universe of p53 targets 120
Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction. 119
Structural studies on mechanisms to activate mutant p53. 119
The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein 116
More targets, more pathways and more clues for mutant p53. 115
High frequency of genomic deletions induced by Me-lex, a sequence selective N3-adenine methylating agent, at the Hprt locus in Chinese hamster ovary cells. 115
Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation 113
DHX30 coordinates cytoplasmic translation and mitochondrial function contributing to cancer cell survival 113
PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cells. 112
Identification of a novel TP53 germline mutation in a large Italian Li-Fraumeni syndrome Family. 110
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites. 110
Transcriptional defect of an inherited NKX2-5 haplotype comprising a SNP, a nonsynonymous and a synonymous mutation, associated with human congenital heart disease. 109
XRCC1 deficiency influences the cytotoxicity and the genomic instability induced by Me-lex, a specific inducer of N3-methyladenine. 108
Influences of base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent 107
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53. 106
Functional diversity in the gene network controlled by the master regulator p53 in humans. 106
Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences 106
Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. 105
The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage. 103
PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells. 103
TranSNPs: A class of functional SNPs affecting mRNA translation potential revealed by fraction-based allelic imbalance 103
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma. 102
Functional evolution of the p53 regulatory network through its target response elements 101
Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype. 100
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 98
Transcriptional functionality of germ line p53 mutants influences cancer phenotype 97
Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction 96
Regulation of human PTCH1b expression by different 5' untranslated region cis-regulatory elements 96
Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency 91
The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes. 90
The influence of quadruplex structure in proximity to P53 target sequences on the transactivation potential of p53 alpha isoforms 88
Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma. 85
Studying RNP Composition with RIP 84
Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site 83
Evaluating the influence of a g-quadruplex prone sequence on the transactivation potential by wild-type and/or mutant p53 family proteins through a yeast-based functional assay 80
Totale 14.455
Categoria #
all - tutte 65.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.036
Totale 66.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.087 0 0 0 0 0 180 111 119 98 177 174 228
2021/20221.340 67 190 18 53 53 40 60 230 108 100 140 281
2022/20231.873 311 247 45 281 165 271 9 116 223 18 109 78
2023/2024672 39 65 44 29 67 210 53 47 7 23 14 74
2024/20252.704 25 18 159 529 173 330 163 209 280 461 176 181
2025/20262.845 393 157 733 693 628 241 0 0 0 0 0 0
Totale 15.317